Global pharmaceutical and life sciences company Bayer is eyeing the growing market for over-the-counter (OTC) products in India. And has a strategy in place for expansion.
On June 28, 2022, a US Court dismissed all claims and counterclaims pending in the case with prejudice, pursuant to a joint stipulation of dismissal filed by the parties, the Hyderabad-based drug major said in a statement.
The job cuts, previously projected by Chief Executive Vas Narasimhan to be in the "single-digit thousands", are part of a restructuring programme the Swiss pharmaceutical group announced in April, targeting savings of at least $1 billion by 2024.
The Sebi warning letter observes that the company had ''disclosed very limited and restricted information'' and that it did not disclose the detailed reasons and neither considered USFDA's observations as serious.
The said agreement resolves all claims between the parties relating to the company's products and also covers Indivior's and Aquestive's patent infringement allegations, Dr Reddy's Laboratories said in a regulatory filing.
The acquisition will support Dr. Reddy's efforts to speed up and increase patient access to affordable medications, the company’s statement read.
"Industry insiders and investors will probably not be rattled by the news as was evidenced by Biocon share price being largely unaffected by the charge, " said analyst Salil Kallianpur.
The planned facility will house several centres for clinical excellence that will cater to the functions of cardiac sciences, organ transplant, neurosciences, orthopaedics, oncology, urology and nephrology, gastro sciences, and woman and child wellness.
After integration of these platforms with UHI, users can avail a large number of health services like tele-consultation with a doctor, availing services of a lab, transferring test reports or health records digitally to the doctor and paying digitally for any of the above services.
The journal said that the domestically developed vaccine is “safe, well-tolerated and immunogenic in pediatric subjects.” Bharat Biotech confirmed the development in a tweet.
SII manufactures India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer.
According to Cipla, this new formulation does not require refrigeration, has a sweet taste and is easy to administer to infants and children of different weights and ages.
ASG has been on an acquisition spree through the pandemic and has recently acquired two sizeable chains in North India, emerging as a significant healthcare platform.
The FDA reviewers said in briefing documents published on Sunday evening that their evaluation did not reveal any new safety concerns related to the use of the vaccine in young children.
As per the latest enforcement report by USFDA, the company, which is a unit of Bengaluru-headquartered Strides Pharma Science, is recalling 6,78,829 bottles of the blood pressure lowering drug in the US market.
RIL and Apollo Global Management together have made an offer for Walgreens Boots Alliance’s Boots business that makes them the strongest bidder for the deal.
US market for the suspension is pegged at around $41 million and this product will be manufactured at the company’s facility at Bengaluru.
Dasatinib tablets are used for the treatment of adult patients with leukaemia-related ailments.
As per the company, the product will be manufactured at Lupin’s Nagpur facility in India
Novavax said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the Serum Institute of India.
Zydus Lifesciences announced receiving final approval from the US health regulator to commercialize the drug with a market size of $195 million.
Copyright©2022 Living Media India Limited. For reprint rights: Syndications Today